loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Alti-Sulfasalazine, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Alti-Sulfasalazine

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Forms

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    2D Structure
    Also known as:
    Molecular Formula
    C18H14N4O5S
    Molecular Weight
    398.4  g/mol
    InChI Key
    OQANPHBRHBJGNZ-BKUYFWCQSA-N
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (3Z)-6-oxo-3-[[4-(pyridin-2-ylsulfamoyl)phenyl]hydrazinylidene]cyclohexa-1,4-diene-1-carboxylic acid
    2.1.2 InChI
    InChI=1S/C18H14N4O5S/c23-16-9-6-13(11-15(16)18(24)25)21-20-12-4-7-14(8-5-12)28(26,27)22-17-3-1-2-10-19-17/h1-11,20H,(H,19,22)(H,24,25)/b21-13-
    2.1.3 InChI Key
    OQANPHBRHBJGNZ-BKUYFWCQSA-N
    2.1.4 Canonical SMILES
    C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O
    2.1.5 Isomeric SMILES
    C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N/N=C\3/C=CC(=O)C(=C3)C(=O)O
    2.2 Create Date
    2005-03-26
    3 Chemical and Physical Properties
    Molecular Weight 398.4 g/mol
    Molecular Formula C18H14N4O5S
    XLogP32.3
    Hydrogen Bond Donor Count3
    Hydrogen Bond Acceptor Count9
    Rotatable Bond Count6
    Exact Mass398.06849073 g/mol
    Monoisotopic Mass398.06849073 g/mol
    Topological Polar Surface Area146 A^2
    Heavy Atom Count28
    Formal Charge0
    Complexity804
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count1
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Information
    1 of 6  
    Drug NameAzulfidine
    PubMed HealthSalicylate (Oral route, Rectal route)
    Drug ClassesAntirheumatic, Gastrointestinal Agent
    Drug LabelAZULFIDINE EN-tabs Tablets contain sulfasalazine, formulated in a delayed release tablet (enteric-coated), 500 mg, for oral administration.AZULFIDINE EN-tabs Tablets are film coated with cellulose acetate phthalate to retard disintegration of the tab...
    Active IngredientSulfasalazine
    Dosage FormTablet; Suspension
    RouteOral
    Strength500mg; 250mg/5ml
    Market StatusPrescription
    CompanyPharmacia And Upjohn

    2 of 6  
    Drug NameAzulfidine en-tabs
    PubMed HealthSulfasalazine (By mouth)
    Drug LabelAZULFIDINE EN-tabs Tablets contain sulfasalazine, formulated in a delayed release tablet (enteric-coated), 500 mg, for oral administration.AZULFIDINE EN-tabs Tablets are film coated with cellulose acetate phthalate to retard disintegration of the tab...
    Active IngredientSulfasalazine
    Dosage FormTablet; Tablet, delayed release
    Routeoral; Oral
    Strength500mg
    Market StatusPrescription
    CompanyPharmacia Upjohn; Pharmacia And Upjohn

    3 of 6  
    Drug NameSulfasalazine
    Drug LabelSulfasalazine Tablets USP, 500 mg for Oral AdministrationTherapeutic classification: Anti-inflammatory agent.Chemical designation: 5-[[p-(2-Pyridylsulfamoyl)phenyl]azo]salicylic acid.Chemical Structure:The molecular weight of sulfasalazine is 398.39....
    Active IngredientSulfasalazine
    Dosage FormTablet; Tablet, delayed release
    RouteOral
    Strength500mg
    Market StatusPrescription
    CompanyVintage Pharms; Watson Labs

    4 of 6  
    Drug NameAzulfidine
    PubMed HealthSalicylate (Oral route, Rectal route)
    Drug ClassesAntirheumatic, Gastrointestinal Agent
    Drug LabelAZULFIDINE EN-tabs Tablets contain sulfasalazine, formulated in a delayed release tablet (enteric-coated), 500 mg, for oral administration.AZULFIDINE EN-tabs Tablets are film coated with cellulose acetate phthalate to retard disintegration of the tab...
    Active IngredientSulfasalazine
    Dosage FormTablet; Suspension
    RouteOral
    Strength500mg; 250mg/5ml
    Market StatusPrescription
    CompanyPharmacia And Upjohn

    5 of 6  
    Drug NameAzulfidine en-tabs
    PubMed HealthSulfasalazine (By mouth)
    Drug LabelAZULFIDINE EN-tabs Tablets contain sulfasalazine, formulated in a delayed release tablet (enteric-coated), 500 mg, for oral administration.AZULFIDINE EN-tabs Tablets are film coated with cellulose acetate phthalate to retard disintegration of the tab...
    Active IngredientSulfasalazine
    Dosage FormTablet; Tablet, delayed release
    Routeoral; Oral
    Strength500mg
    Market StatusPrescription
    CompanyPharmacia Upjohn; Pharmacia And Upjohn

    6 of 6  
    Drug NameSulfasalazine
    Drug LabelSulfasalazine Tablets USP, 500 mg for Oral AdministrationTherapeutic classification: Anti-inflammatory agent.Chemical designation: 5-[[p-(2-Pyridylsulfamoyl)phenyl]azo]salicylic acid.Chemical Structure:The molecular weight of sulfasalazine is 398.39....
    Active IngredientSulfasalazine
    Dosage FormTablet; Tablet, delayed release
    RouteOral
    Strength500mg
    Market StatusPrescription
    CompanyVintage Pharms; Watson Labs

    Post Enquiry
    POST ENQUIRY